243 related articles for article (PubMed ID: 31894325)
1. Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non‑small cell lung cancer.
Park S; Lim JM; Chun JN; Lee S; Kim TM; Kim DW; Kim SY; Bae DJ; Bae SM; So I; Kim HG; Choi JY; Jeon JH
Int J Oncol; 2020 Feb; 56(2):559-567. PubMed ID: 31894325
[TBL] [Abstract][Full Text] [Related]
2. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8.
Wang S; Zhang X; Yang C; Xu S
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):955-967. PubMed ID: 31381176
[TBL] [Abstract][Full Text] [Related]
4. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer.
Chen CY; Jan YH; Juan YH; Yang CJ; Huang MS; Yu CJ; Yang PC; Hsiao M; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):630-5. PubMed ID: 23267084
[TBL] [Abstract][Full Text] [Related]
5. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
6. Fucosylation genes as circulating biomarkers for lung cancer.
Leng Q; Tsou JH; Zhan M; Jiang F
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2109-2115. PubMed ID: 30101373
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
[TBL] [Abstract][Full Text] [Related]
8. Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.
Honma R; Kinoshita I; Miyoshi E; Tomaru U; Matsuno Y; Shimizu Y; Takeuchi S; Kobayashi Y; Kaga K; Taniguchi N; Dosaka-Akita H
Oncology; 2015; 88(5):298-308. PubMed ID: 25572677
[TBL] [Abstract][Full Text] [Related]
9. Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer Cells.
Ohkawa Y; Kitano M; Maeda K; Nakano M; Kanto N; Kizuka Y; Seike M; Azuma A; Yamaguchi Y; Ookawara T; Miyoshi E; Taniguchi N
Antioxid Redox Signal; 2023 Jun; 38(16-18):1201-1211. PubMed ID: 36606688
[No Abstract] [Full Text] [Related]
10. Death receptor 5 is activated by fucosylation in colon cancer cells.
Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
[TBL] [Abstract][Full Text] [Related]
11. A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.
Agrawal P; Fontanals-Cirera B; Sokolova E; Jacob S; Vaiana CA; Argibay D; Davalos V; McDermott M; Nayak S; Darvishian F; Castillo M; Ueberheide B; Osman I; Fenyö D; Mahal LK; Hernando E
Cancer Cell; 2017 Jun; 31(6):804-819.e7. PubMed ID: 28609658
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells.
Shao K; Chen ZY; Gautam S; Deng NH; Zhou Y; Wu XZ
Glycobiology; 2016 Feb; 26(2):142-54. PubMed ID: 26443198
[TBL] [Abstract][Full Text] [Related]
13. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes.
Liu Y; Liu L; Yu T; Lin HC; Chu D; Deng W; Yan MX; Li J; Yao M
Mol Med Rep; 2016 Dec; 14(6):5093-5103. PubMed ID: 27840927
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L
Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464
[TBL] [Abstract][Full Text] [Related]
17. Fucosylation in Urological Cancers.
Fujita K; Hatano K; Hashimoto M; Tomiyama E; Miyoshi E; Nonomura N; Uemura H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948129
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
20. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]